Dermatology is also a strength for Mayne Pharma. August results will be very interesting.
Also don't underestimate the relationship with Mithra and the potential of Nextstellis in the menopause market. Trials are ongoing at present. Menopause is a massive market all over the world.
Cheers.....D
MYX Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)